Form 4: Clover Health Exec Sells Shares for Tax Withholding

Clover Health Investments Corp. officer Jamie L. Reynoso sold shares to cover tax obligations related to RSU vesting, not as a discretionary trade.

Summary

• Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold 6,350 shares of Class A Common Stock on June 15, 2026.
• The sale was executed at a weighted average price of $4.61, with individual transactions ranging from $4.61 to $4.64.
• These shares were sold to cover tax withholding obligations triggered by the vesting of restricted stock units (RSUs).
• The transaction was a mandatory 'sell to cover' as per the company's equity incentive plan and not a discretionary decision by the reporting person.
• Following the transaction, Reynoso beneficially owns 2,843,571 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a routine administrative event related to executive compensation and tax obligations, rather than a reflection of the executive's view on the company's future performance.

Positives

• The sale was a mandatory 'sell to cover' to satisfy tax obligations, indicating the company's established process for managing RSU vesting tax liabilities.
• The reporting person continues to hold a significant number of shares (2,843,571) after the transaction.

Negatives

• A portion of the executive's equity compensation was sold, reducing their direct shareholding.

Risks

• The filing does not explicitly mention any new or emerging risks.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Management Comments

• The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ('RSUs').
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions, particularly for executives managing equity compensation. The 'sell to cover' mechanism is a common practice to manage tax liabilities upon vesting of RSUs, preventing unexpected cash outlays for the executive.

Stakeholder Impact

• Shareholders: The sale is a pre-planned event to cover taxes and does not indicate a change in the executive's long-term conviction in the company. The overall beneficial ownership remains substantial.

Next Steps

• No specific next steps are outlined in this filing.

Key Dates

Keywords

Form 4, Insider Trading, Clover Health, CLOV, RSU Vesting, Tax Withholding, Share Sale, Executive Compensation